Characterization of Plasmodium falciparum Adenylyl Cyclase-β and its role in Erythrocytic stage parasites

22Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

The most severe form of human malaria is caused by the parasite Plasmodium falciparum. The second messenger cAMP has been shown to be important for the parasite's ability to infect the host's liver, but its role during parasite growth inside erythrocytes, the stage responsible for symptomatic malaria, is less clear. The P. falciparum genome encodes two adenylyl cyclases, the enzymes that synthesize cAMP, PfACα and PfACβ. We now show that one of these, PfACβ, plays an important role during the erythrocytic stage of the P. falciparum life cycle. Biochemical characterization of PfACβ revealed a marked pH dependence, and sensitivity to a number of small molecule inhibitors. These inhibitors kill parasites growing inside red blood cells. One particular inhibitor is selective for PfACβ relative to its human ortholog, soluble adenylyl cyclase (sAC); thus, PfACβ represents a potential target for development of safe and effective antimalarial therapeutics. © 2012 Salazar et al.

Cite

CITATION STYLE

APA

Salazar, E., Bank, E. M., Ramsey, N., Hess, K. C., Deitsch, K. W., Levin, L. R., & Buck, J. (2012). Characterization of Plasmodium falciparum Adenylyl Cyclase-β and its role in Erythrocytic stage parasites. PLoS ONE, 7(6). https://doi.org/10.1371/journal.pone.0039769

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free